Abstract

Retrograde coronary venous infusion provides both increased regional fibroblast growth factor 2 (FGF-2) concentrations and homogeneous dissemination of bone marrow mesenchymal stem cells (MSCs) across the myocardium. We determined the effects of retrograde delivery of combined FGF-2 and MSCs on

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call